Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Simulations PlusFRA:SD3 82 Days Payable is 20.43 as of May. 2026, which is 100% above its 10-year median of 10.21. GuruFocus rates FRA:SD3 with a GF Score™ of 82/100 and a GF Value™ of €29.72. The stock has 7 warning signs investors should review. Among 608 Healthcare Providers & Services companies, Simulations Plus ranks worse than 87.17% on this metric.
The historical rank and industry rank for Simulations Plus's Days Payable or its related term are showing as below:
FRA:SD3'
s Days Payable Range Over the Past 10 Years
Min: 5.07 Med: 10.21 Max: 14.65
Current: 14.65
During the past 13 years, Simulations Plus's highest Days Payable was 14.65. The lowest was 5.07. And the median was 10.21.
FRA:SD3's Days Payable is ranked worse than 87.17% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 56.785
vs FRA:SD3: 14.65
Simulations Plus's Days Payable
increased
from May. 2025 (18.47) to May. 2026 (20.43).
It may suggest that Simulations Plusdelayed paying its suppliers.
The historical data trend for Simulations Plus's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:SD3 vs CTEV, TBRG, CARL: Days Payable Comparison
For the Health Information Services subindustry, Simulations Plus's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Simulations Plus Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Simulations Plus's Days Payable distribution charts can be found below:
* The bar in red indicates where Simulations Plus's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Simulations Plus's Days Payable for the fiscal year that ended in Aug. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Simulations Plus (FRA:SD3) has a Days Payable of 20.43 as of May. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Simulations Plus and its competitors. This is 100% above median its historical median of 10.21. Over the past decade, Simulations Plus' Days Payable has ranged from 5.07 to 14.65. According to the industry distribution chart, Simulations Plus ranks #530 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 87.2%.
Is Simulations Plus' Days Payable too high?
Simulations Plus' current Days Payable of 20.43 is 100% above median its 10-year median of 10.21. Over the past 10 years, this metric has ranged from a low of 5.07 to a high of 14.65. The Healthcare Providers & Services industry median Days Payable is 56.79. Simulations Plus' value of 20.43 is 64% below this industry median. Based on the distribution chart, Simulations Plus ranks #530 out of 608 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Simulations Plus has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Simulations Plus' Days Payable compare to CTEV and TBRG?
According to the Healthcare Providers & Services industry distribution chart, Simulations Plus ranks #530 out of 608 companies for Days Payable. This places Simulations Plus in the lower half of its industry. The industry median Days Payable is 56.79. Simulations Plus' value of 20.43 is 64% below this benchmark. Historically, Simulations Plus' own Days Payable has ranged from 5.07 to 14.65 over the past decade. While the company's 10-year median is 10.21 vs. the industry median of 56.79, Simulations Plus has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 56.79, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Simulations Plus's current Days Payable of 20.43 is 64% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Simulations Plus and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 56.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Simulations Plus's current Days Payable is 20.43, which is 100% above median its own 10-year median of 10.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Simulations Plus stock overvalued right now?
Simulations Plus (FRA:SD3) has a current Days Payable of 20.43. The stock's GF Value™ is €29.72, compared to a current price of €15.50 — trading 47.8% below its estimated fair value. The current Days Payable is 20.43, which is 100% above median its 10-year median of 10.21 and 64% below the Healthcare Providers & Services industry median of 56.79. Simulations Plus' overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Simulations Plus (FRA:SD3), the current Days Payable is 20.43 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Simulations Plus (FRA:SD3) Overvalued in 2026?
Based on GuruFocus' analysis, Simulations Plus stock appears to be undervalued.
The current stock price of €15.50 is trading 47.8% below its estimated GF Value™ of €29.72.
Key valuation signals for FRA:SD3:
Days Payable: 20.43 (100% above median its 10-year median of 10.21)
GF Value™: €29.72 vs. price of €15.50 (47.8% below fair value)
Industry Position: 64% below the Healthcare Providers & Services median (#530 of 608)
No single metric tells the full story. See the FRA:SD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
82GF Score
Get the complete analysis for FRA:SD3
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:SD3 has been successfully added to your 
